Adverse Drug Events (ADEs) are potentially very dangerous to patients and are amongst the top causes of morbidity and mortality. Monitoring & reporting of ADEs is required by pharma companies...
Earlier this month, it was reported that the Centers for Disease Control and Prevention (CDC) instructed states to sign data use agreements that commit them for the first time to sharing personal...
If 2020 has taught us anything, it’s that the need for faster development, testing, and regulatory approval for new medical treatments is critical to public health. With the acceleration of...
Natural Language Processing (NLP) has been a technology to watch over the past few years, but in 2020 it emerged as a mission-critical tool for businesses. With the advent of...
When it comes to clinical annotation projects, many times NER is not enough. Suppose that you want to identify all the diseases that were diagnosed to a group of patients...